CAS 1616413-96-7

UCB9608

CAS : 1616413-96-7

Formule : C₂₀H₂₆N₈O₂

Degré de pureté : 99.80%

Masse moléculaire : 410.4728

Ref: IN-DA01FSIR

(S)-4-(6-Amino-1-Methyl-1H-Pyrazolo[3,4-D]Pyrimidin-4-Yl)-N-(4-Methoxy-2-Methylphenyl)-3-Methylpiperazine-1-Carboxamide

CAS : 1616413-96-7

(S)-4-(6-Amino-1-Methyl-1H-Pyrazolo[3,4-D]Pyrimidin-4-Yl)-N-(4-Methoxy-2-Methylphenyl)-3-Methylpiperazine-1-Carboxamide

Degré de pureté : 99%

Masse moléculaire : 410.47g/mol

Ref: 54-OR1023087

UCB9608

CAS : 1616413-96-7

UCB9608

Degré de pureté : ≥95%

Masse moléculaire : 410.47g/mol

Ref: 54-BUP15268

UCB9608

CAS : 1616413-96-7

UCB9608 is a selective and orally active PI4KIIIβ inhibitor (IC50: 11 nM), selective over PI3KC2 α, β, and γ lipid kinases.

Formule : C₂₀H₂₆N₈O₂

Degré de pureté : 97.53% - 99.59%

Couleur et forme : Solid

Masse moléculaire : 410.47

Ref: TM-TQ0009

UCB9608

CAS : 1616413-96-7

UCB9608 is a lipid kinase inhibitor that targets the linker region of the lipid kinase enzyme. It has been shown to inhibit the proliferation of cancer cells in vitro and in vivo. UCB9608 shows potent antiviral activity against HIV-1 and HSV-2, and it inhibits the proliferation of human papillomavirus (HPV) cell lines. This drug also has immunosuppressive properties, which may be due to its ability to interfere with regulatory T cells and antigen presenting cells. The effective dose for UCB9608 is unknown, but it is likely higher than 100 mg/kg/day since this was observed in other studies.

Formule : C₂₀H₂₆N₈O₂

Degré de pureté : Min. 95%

Masse moléculaire : 410.47 g/mol

Ref: 3D-RPC41396